Literature DB >> 3011378

[Double infection with early summer meningoencephalitis virus and Borrelia burgdorferi].

W Kristoferitsch, G Stanek, C Kunz.   

Abstract

A 68-year-old woman developed a meningoencephalitis 18 days after a tick bite. IgG and IgM antibodies against tick-encephalitis virus were demonstrated, by enzyme-linked immunoabsorbent assay, in both serum and cerebrospinal fluid (csf). Lymphoplasmocytic pleocytosis was present in csf for over six weeks, as was an increased IgM level. Three weeks after the onset of neurological symptoms and clearing of the encephalitis there occurred multiple peripheral pareses in the left leg which were slow to regress. Retrospectively, IgM and IgG antibodies against Borrelia burgdorferi were demonstrated in deep-frozen serum and csf. Since IgG antibodies against Borrelia burgdorferi, locally synthesised in csf, could also be demonstrated, it must be assumed that the patient had a double infection. It is suggested that in confirmed cases of tick-encephalitis with an atypical course an additional infection with Borrelia should be considered, because if present the latter can be successfully treated with high doses of penicillin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011378     DOI: 10.1055/s-2008-1068546

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  10 in total

1.  Clinical features of double infection with tick-borne encephalitis and Lyme borreliosis transmitted by tick bite.

Authors:  I Logina; A Krumina; G Karelis; L Elsone; L Viksna; B Rozentale; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-05       Impact factor: 10.154

2.  Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

Authors:  J Tomazic; A Ihan; F Strle; J Cimperman; J Stare; M Maticic; B Zakotnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 3.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

5.  Risk for human tick-borne encephalitis, borrelioses, and double infection in the pre-Ural region of Russia.

Authors:  E I Korenberg; L Y Gorban; Y V Kovalevskii; V I Frizen; A S Karavanov
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

6.  Epidemiological survey of tick-borne encephalitis virus and Anaplasma phagocytophilum co-infections in patients from regions of the Czech Republic endemic for tick-borne diseases.

Authors:  Petr Zeman; Petr Pazdiora; Vaclav Chmelik; Jiri Januska; Karel Sedivy; Alberto A Guglielmone; Jorge A Iriarte; Zuzana Medkova
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in patients with acute meningitis or meningoencephalitis.

Authors:  J Cimperman; V Maraspin; S Lotric-Furlan; E Ruzić-Sabljić; T Avsic-Zupanc; R N Picken; F Strle
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

8.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28

9.  Concomitant tickborne encephalitis and human granulocytic ehrlichiosis.

Authors:  Stanka Lotric-Furlan; Miroslav Petrovec; Tatjana Avsic-Zupanc; Franc Strle
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

10.  Are patients with erythema migrans who have leukopenia and/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus?

Authors:  Franc Strle; Petra Bogovič; Jože Cimperman; Vera Maraspin; Katarina Ogrinc; Tereza Rojko; Daša Stupica; Lara Lusa; Tatjana Avšič-Županc; Katja Strašek Smrdel; Mateja Jelovšek; Stanka Lotrič-Furlan
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.